New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AnaptysBio, Inc.
ANAB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

524M

Biotechnology

Next Earning date - 08 May 2025

524M

Biotechnology

Next Earning date - 08 May 2025

17.08USD

Shape-0.49 ( -2.79%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

41
favorite-chart

Volume Buzz

49%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

59%

Quote Panel

Shape
Updated March 24, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

ANAB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$42M

Shape-3%

2025-Revenue

$5.39

Shape-600%

2025-EPS

$35M

Shape-819%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

38.50(125.41%)

Number of analyst

2

Last analyst upgrade/downgrade

Wolfe Research

initialise

Previous: Not converted

2025-02-03

Now: Outperform

H.C. Wainwright

downgrade

Previous: Buy

2024-12-11

Now: Neutral

BTIG

downgrade

Previous: Not converted

2024-12-02

Now: Neutral

Wedbush

upgrade

Previous: Neutral

2024-03-12

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-1.58
vs -1.31

Q2.23

arrow
arrow

N/A

-1.50
vs -1.15

Q3.23

arrow
arrow

N/A

-1.41
vs -1.18

Q4.23

arrow
arrow

N/A

-1.59
vs -0.93

Q1.24

arrow
arrow

N/A

-1.64
vs -1.58

Q2.24

arrow
arrow

N/A

-1.71
vs -1.50

Q3.24

arrow
arrow

N/A

-1.14
vs -1.41

Q4.24

arrow
arrow

N/A

-0.72
vs -1.59

Q1.25

arrow
arrow

N/A

-1.30
vs -1.64

Q2.25

arrow
arrow

N/A

-1.40
vs -1.71

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+42%

1.4M  vs 970K

Q2.23

arrow
arrow

+185%

3.5M  vs 1.2M

Q3.23

arrow
arrow

+157%

3.3M  vs 1.3M

Q4.23

arrow
arrow

+32%

9M  vs 6.8M

Q1.24

arrow
arrow

+422%

7.2M  vs 1.4M

Q2.24

arrow
arrow

+217%

11M  vs 3.5M

Q3.24

arrow
arrow

+805%

30M  vs 3.3M

Q4.24

arrow
arrow

+379%

43.1M  vs 9M

Q1.25

arrow
arrow

+89%

13.6M  vs 7.2M

Q2.25

arrow
arrow

-22%

8.5M  vs 11M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-25%

-0.25
vs -0.10

Q2.23

arrow
arrow

-27%

-0.27
vs -0.25

Q3.23

arrow
arrow

-31%

-0.31
vs -0.27

Q4.23

arrow
arrow

-48%

-0.48
vs -0.31

Q1.24

arrow
arrow

-92%

-0.92
vs -0.48

Q2.24

arrow
arrow

-472%

-4.72
vs -0.92

Q3.24

arrow
arrow

-39%

-0.39
vs -4.72

Q4.24

arrow
arrow

-31%

-0.31
vs -0.39

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

118

118
vs 120

-2%

Q2.23

arrow
arrow

123

123
vs 118

4%

Q3.23

arrow
arrow

122

122
vs 123

-1%

Q4.23

arrow
arrow

124

124
vs 122

2%

Q1.24

arrow
arrow

140

140
vs 124

13%

Q2.24

arrow
arrow

138

138
vs 140

-1%

Q3.24

arrow
arrow

174

174
vs 138

26%

Q4.24

arrow
arrow

155

155
vs 174

-11%

Earnings Growth

Latest News